Clinical-stage biotech developing treatments for central nervous system diseases.
Industry: Health Care
First Day Return: +0.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/09/2014 |
Offer Price | $6.00 |
Price Range $6.00 - $6.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/30/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2007 |
Employees at IPO | 6 |
Website www.minervaneurosciences.com |